| Bioactivity | Crisdesalazine (AAD-2004) is an anti-inflammatory agent that simultaneously blocks inflammation mediated by free radicals and prostaglandin E2 (PGE2). Crisdesalazine (AAD-2004) can be used to study neurodegeneration in amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases[1]. | ||||||||||||
| Name | Crisdesalazine | ||||||||||||
| CAS | 927685-43-6 | ||||||||||||
| Formula | C16H14F3NO3 | ||||||||||||
| Molar Mass | 325.28 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Shin JH, et al. Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis. J Neurochem. 2012 Sep;122(5):952-61. |
Crisdesalazine
CAS: 927685-43-6 F: C16H14F3NO3 W: 325.28
Crisdesalazine (AAD-2004) is an anti-inflammatory agent that simultaneously blocks inflammation mediated by free radical
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.